138 related articles for article (PubMed ID: 36105450)
21. Validating an image segmentation program devised for staging lymphoma.
Slattery A
Australas Phys Eng Sci Med; 2017 Dec; 40(4):799-809. PubMed ID: 28971313
[TBL] [Abstract][Full Text] [Related]
22. Snake model-based lymphoma segmentation for sequential CT images.
Chen Q; Quan F; Xu J; Rubin DL
Comput Methods Programs Biomed; 2013 Aug; 111(2):366-75. PubMed ID: 23787027
[TBL] [Abstract][Full Text] [Related]
23. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
Ansell SM; Lesokhin AM; Borrello I; Halwani A; Scott EC; Gutierrez M; Schuster SJ; Millenson MM; Cattry D; Freeman GJ; Rodig SJ; Chapuy B; Ligon AH; Zhu L; Grosso JF; Kim SY; Timmerman JM; Shipp MA; Armand P
N Engl J Med; 2015 Jan; 372(4):311-9. PubMed ID: 25482239
[TBL] [Abstract][Full Text] [Related]
24. A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.
Koç ON; Redfern C; Wiernik PH; Rosenfelt F; Winter JN; Carter WD; Gold DP; Stewart ME; Ghalie RG; Bender JF
J Immunother; 2010; 33(2):178-84. PubMed ID: 20145546
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
[TBL] [Abstract][Full Text] [Related]
26. Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.
Alabed YZ; Aghayev A; Sakellis C; Van den Abbeele AD
Clin Nucl Med; 2015 Nov; 40(11):e528-9. PubMed ID: 26284765
[TBL] [Abstract][Full Text] [Related]
27. Diffuse large B-cell lymphoma segmentation in PET-CT images via hybrid learning for feature fusion.
Yuan C; Zhang M; Huang X; Xie W; Lin X; Zhao W; Li B; Qian D
Med Phys; 2021 Jul; 48(7):3665-3678. PubMed ID: 33735451
[TBL] [Abstract][Full Text] [Related]
28. Computed Tomography Image Features under Convolutional Neural Network Algorithm in Analysis of Inflammatory Factor Level and Prognosis of Patients with Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure.
Xie Z; Ding L; Li Y
J Healthc Eng; 2021; 2021():2110612. PubMed ID: 34790343
[TBL] [Abstract][Full Text] [Related]
29. The Value of
Vekens K; Everaert H; Neyns B; Ilsen B; Decoster L
Clin Lung Cancer; 2021 Sep; 22(5):432-440. PubMed ID: 33879398
[TBL] [Abstract][Full Text] [Related]
30. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors.
Razak AR; Cleary JM; Moreno V; Boyer M; Calvo Aller E; Edenfield W; Tie J; Harvey RD; Rutten A; Shah MA; Olszanski AJ; Jäger D; Lakhani N; Ryan DP; Rasmussen E; Juan G; Wong H; Soman N; Smit MD; Nagorsen D; Papadopoulos KP
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33046621
[TBL] [Abstract][Full Text] [Related]
32. Comparison of 11 automated PET segmentation methods in lymphoma.
Weisman AJ; Kieler MW; Perlman S; Hutchings M; Jeraj R; Kostakoglu L; Bradshaw TJ
Phys Med Biol; 2020 Nov; 65(23):235019. PubMed ID: 32906088
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A;
Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758
[TBL] [Abstract][Full Text] [Related]
34. Metabolic activity by
Kaira K; Higuchi T; Naruse I; Arisaka Y; Tokue A; Altan B; Suda S; Mogi A; Shimizu K; Sunaga N; Hisada T; Kitano S; Obinata H; Yokobori T; Mori K; Nishiyama M; Tsushima Y; Asao T
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):56-66. PubMed ID: 28828507
[TBL] [Abstract][Full Text] [Related]
35. The utility of
Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
[TBL] [Abstract][Full Text] [Related]
36. CD4
Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
[TBL] [Abstract][Full Text] [Related]
37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
38. [The Application Value of True Whole-body PET/CT Scanning Protocol in Patients of Extranodal NK/T Cell Lymphoma].
Li FL; Su MG; Shi DZ; Liang FL; Li L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):245-251. PubMed ID: 32220195
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma.
Tateishi U; Tatsumi M; Terauchi T; Ando K; Niitsu N; Kim WS; Suh C; Ogura M; Tobinai K
Cancer Sci; 2015 Feb; 106(2):186-93. PubMed ID: 25495273
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials.
Hao C; Tian J; Liu H; Li F; Niu H; Zhu B
Medicine (Baltimore); 2017 Jun; 96(26):e7325. PubMed ID: 28658143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
